Maternal illicit substance use
This will be defined as any and number of positive urine drug screens for illicit substances at the 6-, 12-, and 18-month follow-up assessment visits. Data will be abstracted from the opioid treatment program records. The proportion of participants with any positive screen and the mean number of positive screens at each time point will be compared between the 2 study arms.